HUMPHREY RACHEL - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, HUMPHREY RACHEL's relationship to Pyxis Oncology, Inc. (PYXS) is Director, and currently has 96,805 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PYXS insiders.
Data Source: SEC.
HUMPHREY RACHEL - Insider Non-Derivative Transactions of PYXS Common Stock
HUMPHREY RACHEL - Insider Non-Derivative Transactions at PYXS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | Acquisition -- (Common Stock) | 38741 | 0 | 96805 |
| Mar 25, 2023 | Acquisition -- (Common Stock) | 58064 | 0 | 58064 |